Quest Diagnostics Inc Finance Lease, Right-of-Use Asset, Accumulated Amortization
Quest Diagnostics Inc (DGX) had Finance Lease, Right-of-Use Asset, Accumulated Amortization of $4.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization · last filed 2026-02-26
- 2025-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $4.00M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $1.00M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $5.00M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $3.00M.
| Period end | Finance Lease, Right-of-Use Asset, Accumulated Amortization |
|---|---|
| 2025-12-31 | $4.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.00M 10-K · filed 2026-02-26 |
| 2023-12-31 | $5.00M 10-K · filed 2025-02-20 |
| 2022-12-31 | $3.00M 10-K · filed 2024-02-22 |
| 2021-12-31 | $8.00M 10-K · filed 2023-02-21 |
| 2020-12-31 | $14.00M 10-K · filed 2022-02-28 |
| 2019-12-31 | $24.00M 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |